TRex Bio, Inc. (TRXB)
NASDAQ: TRXB · Real-Time Price · USD
15.49
+0.25 (1.64%)
At close: Oct 22, 2026, 4:00 PM EDT
15.50
+0.01 (0.06%)
After-hours: Oct 22, 2026, 7:30 PM EDT
TRex Bio Employees
TRex Bio had 60 employees as of June 30, 2026. The number of employees increased by 6 or 11.11% since the number was reported on December 31, 2025. That makes TRex Bio the 34,268th largest employer in the world and 4,548th in the United States.
Employees
60
Change
6
Growth
11.11%
Revenue / Employee
n/a
Profits / Employee
-$773,200
Market Cap
417.29M
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 60 | 6 | 11.11% |
| Dec 31, 2025 | 54 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| ProKidney | 231 |
| ARS Pharmaceuticals | 200 |
| Assembly Biosciences | 73 |
| Prothena Corporation | 67 |
| AgomAb Therapeutics NV | 62 |
| Tectonic Therapeutic | 60 |
| Altimmune | 57 |
TRXB News
- 9 days ago - TRexBio Announces Closing of Initial Public Offering - GlobeNewsWire
- 10 days ago - Opening Day: Biotech duo Retension, TRex Bio come public - TheFly
- 13 days ago - TRex Bio opens at $13.50, IPO priced at $14 per share - TheFly
- 13 days ago - TRex Bio indicated to open at $13.90, IPO priced at $14 - TheFly
- 13 days ago - TRex Bio indicated to open at $14.05, IPO priced at $14 - TheFly
- 13 days ago - TRex Bio indicated to open at $14.50, IPO priced at $14 - TheFly
- 14 days ago - TRex Bio 8.333M share IPO priced at $14.00 - TheFly
- 14 days ago - TRexBio Announces Pricing of Initial Public Offering - GlobeNewsWire